{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:37:37Z","timestamp":1762101457496},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/cco.0b013e328363e0ef","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T11:50:22Z","timestamp":1376394622000},"page":"546-552","source":"Crossref","is-referenced-by-count":16,"title":["Management of sarcomas of the uterus"],"prefix":"10.1097","volume":"25","author":[{"given":"Akiva P.","family":"Novetsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew A.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-15-20210128","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ygyno.2003.12.029","article-title":"Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.","volume":"93","author":"Brooks","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R2-15-20210128","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0959-8049(97)00040-3","article-title":"Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality.","volume":"33","author":"Nordal","year":"1997","journal-title":"Eur J Cancer"},{"key":"R4-15-20210128","first-page":"321","article-title":"Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas J Clin P","volume":"55","author":"McCluggage","year":"2002","journal-title":"athol"},{"key":"R5-15-20210128","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/(SICI)1096-9896(199911)189:3<338::AID-PATH429>3.0.CO;2-Q","article-title":"Analysis by comparative genomic hybridization of epithelial and spindle cell components in sarcomatoid carcinoma and carcinosarcoma: histogenetic aspects.","volume":"189","author":"Torenbeek","year":"1999","journal-title":"J Pathol"},{"key":"R6-15-20210128","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/modpathol.3800654","article-title":"DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis.","volume":"19","author":"Taylor","year":"2006","journal-title":"Modern Pathol"},{"key":"R8-15-20210128","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijgo.2008.12.008","article-title":"FIGO., committee on gynecologic, oncology., FIGO., staging for uterine, sarcomas.","volume":"104","author":"Prat","year":"2009","journal-title":"Int J Gynecol Obstet"},{"key":"R9-15-20210128","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijgo.2008.12.008","article-title":"FIGO staging for uterine sarcomas.","volume":"104","author":"Prat","year":"2009","journal-title":"Int J Gynecol Obstet"},{"key":"R10-15-20210128","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/0002-9378(90)91298-Q","article-title":"Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas.","volume":"162","author":"Leibsohn","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 4","key":"R11-15-20210128","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/cncr.2820710440","article-title":"Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study.","volume":"71","author":"Major","year":"1993","journal-title":"Cancer"},{"key":"R12-15-20210128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/gyno.1993.1172","article-title":"Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence.","volume":"50","author":"Goff","year":"1993","journal-title":"Gynecol Oncol"},{"key":"R13-15-20210128","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0090-8258(03)00137-9","article-title":"2nd, Metzinger DS, DiMarco CS, et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.","volume":"89","author":"Giuntoli","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R14-15-20210128","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0090-8258(03)00478-5","article-title":"Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus.","volume":"91","author":"Leitao","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R15-15-20210128","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ygyno.2012.02.014","article-title":"Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis.","volume":"125","author":"Leitao","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R16-15-20210128","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ajog.2008.04.019","article-title":"The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcoma.","volume":"199","author":"Wright","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R17-15-20210128","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ijrobp.2009.02.077","article-title":"The role of adjuvant radiation in uterine sarcomas.","volume":"76","author":"Sampath","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-15-20210128","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ejca.2008.01.019","article-title":"Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).","volume":"44","author":"Reed","year":"2008","journal-title":"Eur J Cancer"},{"key":"R19-15-20210128","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1200\/JCO.1985.3.9.1240","article-title":"A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study.","volume":"3","author":"Omura","year":"1985","journal-title":"J Clin Oncol"},{"key":"R20-15-20210128","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ygyno.2008.11.027","article-title":"Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: results of a prospective study.","volume":"112","author":"Hensley","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R23-15-20210128","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/1097-0142(19830815)52:4<626::AID-CNCR2820520409>3.0.CO;2-E","article-title":"A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas.","volume":"52","author":"Omura","year":"1983","journal-title":"Cancer"},{"key":"R24-15-20210128","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/1097-0142(19850415)55:8<1648::AID-CNCR2820550806>3.0.CO;2-7","article-title":"Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group).","volume":"55","author":"Muss","year":"1985","journal-title":"Cancer"},{"key":"R25-15-20210128","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0002-9378(92)91671-V","article-title":"Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study.","volume":"166","author":"Sutton","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"R26-15-20210128","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1006\/gyno.1996.0220","article-title":"Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study.","volume":"62","author":"Sutton","year":"1996","journal-title":"Gynecol Oncol"},{"key":"R30-15-20210128","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2005.03.018","article-title":"Temozolomide in uterine leiomyosarcomas.","volume":"98","author":"Anderson","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R31-15-20210128","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/cncr.21384","article-title":"A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma: a study by the Spanish Group for Research on Sarcomas.","volume":"104","author":"Garcia del Muro","year":"2005","journal-title":"Cancer"},{"key":"R32-15-20210128","doi-asserted-by":"crossref","first-page":"412503","DOI":"10.1155\/2008\/412503","article-title":"Phase II study of temozolomide and thalidomide in patients with unresectable or metastatic leiomyosarcoma.","volume":"2008","author":"Boyar","year":"2008","journal-title":"Sarcoma"},{"key":"R33-15-20210128","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ygyno.2003.11.023","article-title":"Gynecologic Oncology Group S. Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study.","volume":"92","author":"Look","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R34-15-20210128","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1200\/JCO.2002.11.050","article-title":"Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.","volume":"20","author":"Hensley","year":"2002","journal-title":"J Clin Oncol"},{"key":"R35-15-20210128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2008.03.010","article-title":"Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.","volume":"109","author":"Hensley","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R36-15-20210128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ygyno.2008.02.024","article-title":"Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.","volume":"109","author":"Hensley","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R37-15-20210128","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1634\/theoncologist.2011-0467","article-title":"Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study).","volume":"17","author":"Pautier","year":"2012","journal-title":"Oncologist"},{"key":"R38-15-20210128","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ygyno.2011.11.042","article-title":"A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia.","volume":"125","author":"Mackay","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R39-15-20210128","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1002\/ijc.25843","article-title":"Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma.","volume":"129","author":"Tariq Mahmood","year":"2011","journal-title":"Int J Cancer"},{"key":"R40-15-20210128","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1200\/JCO.2008.20.9890","article-title":"Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas.","volume":"27","author":"George","year":"2009","journal-title":"J Clin Oncol"},{"key":"R41-15-20210128","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ygyno.2009.09.011","article-title":"Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.","volume":"115","author":"Hensley","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R42-15-20210128","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1200\/JCO.2008.21.3223","article-title":"Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043).","volume":"27","author":"Sleijfer","year":"2009","journal-title":"J Clin Oncol"},{"key":"R43-15-20210128","doi-asserted-by":"crossref","first-page":"7135","DOI":"10.1200\/JCO.2005.16.139","article-title":"Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas.","volume":"23","author":"DAdamo","year":"2005","journal-title":"J Clin Oncol"},{"key":"R44-15-20210128","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/annonc\/mdr299","article-title":"Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen.","volume":"23","author":"Verschraegen","year":"2012","journal-title":"Ann Oncol"},{"key":"R47-15-20210128","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00129039-200412000-00008","article-title":"Estrogen and progesterone receptor expression in uterine and extrauterine leiomyosarcomas: an immunohistochemical study.","volume":"12","author":"Kelley","year":"2004","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R48-15-20210128","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ygyno.2009.10.064","article-title":"Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors.","volume":"116","author":"OCearbhaill","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R51-15-20210128","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/cncr.26333","article-title":"A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma.","volume":"118","author":"Zivanovic","year":"2012","journal-title":"Cancer"},{"key":"R52-15-20210128","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/IGC.0b013e3181c9e289","article-title":"Metastatic uterine leiomyosarcomas: a single-institution experience.","volume":"20","author":"Bernstein-Molho","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"R53-15-20210128","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ygyno.2007.02.031","article-title":"2nd, Garrett-Mayer E, Bristow RE, Gostout BS. Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma.","volume":"106","author":"Giuntoli","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R54-15-20210128","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/1097-0142(19821115)50:10<2170::AID-CNCR2820501033>3.0.CO;2-K","article-title":"Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma.","volume":"50","author":"Evans","year":"1982","journal-title":"Cancer"},{"key":"R55-15-20210128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/01.pas.0000213327.86992.d1","article-title":"Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms.","volume":"31","author":"Nucci","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R56-15-20210128","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/PAS.0b013e3182262743","article-title":"Frequency of known gene rearrangements in endometrial stromal tumors.","volume":"35","author":"Chiang","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R57-15-20210128","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ygyno.2010.12.363","article-title":"Incidence of lymph node and adnexal metastasis in endometrial stromal sarcoma.","volume":"121","author":"Dos Santos","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R58-15-20210128","first-page":"1363","article-title":"Lymphadenectomy in uterine low-grade endometrial stromal sarcoma: an analysis of 19 cases and a literature review.","volume":"20","author":"Signorelli","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"R59-15-20210128","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/sj.bjc.6604527","article-title":"Endometrial stromal sarcoma: a population-based analysis.","volume":"99","author":"Chan","year":"2008","journal-title":"Br J Cancer"},{"key":"R60-15-20210128","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ygyno.2009.08.014","article-title":"Hormone receptor expression in uterine sarcomas: prognostic and therapeutic roles.","volume":"115","author":"Ioffe","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"Suppl 3","key":"R61-15-20210128","first-page":"72S","article-title":"Steroid receptors in endolymphatic stromal myosis.","volume":"63","author":"Baker","year":"1984","journal-title":"Obstetr Gynecol"},{"key":"R62-15-20210128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0090-8258(84)90031-3","article-title":"Estradiol and progesterone receptors in two cases of endometrial stromal sarcoma.","volume":"18","author":"Lantta","year":"1984","journal-title":"Gynecol Oncol"},{"key":"R63-15-20210128","first-page":"173","article-title":"Uterine endolymphatic stromal myosis: a collaborative study.","volume":"64","author":"Piver","year":"1984","journal-title":"Obstet Gynecol"},{"key":"R65-15-20210128","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ygyno.2005.11.010","article-title":"Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.","volume":"101","author":"Pink","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R66-15-20210128","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1385\/MO:20:1:87","article-title":"Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma.","volume":"20","author":"Spano","year":"2003","journal-title":"Med Oncol"},{"key":"R67-15-20210128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ygyno.2010.12.360","article-title":"Recurrence patterns and prognosis of endometrial stromal sarcoma and the potential of tyrosine kinase-inhibiting therapy.","volume":"121","author":"Cheng","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R68-15-20210128","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/gyno.1996.0314","article-title":"Endometrial stromal sarcoma: analysis of treatment failures and survival.","volume":"63","author":"Gadducci","year":"1996","journal-title":"Gynecol Oncol"},{"key":"R69-15-20210128","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/PAS.0b013e31824a7b1a","article-title":"The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.","volume":"36","author":"Lee","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R70-15-20210128","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.humpath.2012.08.007","article-title":"YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription-polymerase chain reaction in formalin-fixed, paraffin embedded tumor.","volume":"44","author":"Isphording","year":"2012","journal-title":"Hum Pathol"},{"key":"R71-15-20210128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2012.06.030","article-title":"High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes.","volume":"127","author":"Tanner","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R72-15-20210128","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00000478-198901000-00004","article-title":"Mullerian adenosarcomas of the uterus with sarcomatous overgrowth. A clinicopathological analysis of 10 cases.","volume":"13","author":"Clement","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"R73-15-20210128","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004347-199204000-00001","article-title":"Adenosarcoma of the uterus: a Gynecologic Oncology Group clinicopathologic study of 31 cases.","volume":"11","author":"Kaku","year":"1992","journal-title":"Int J Gynecol Pathol"},{"key":"R75-15-20210128","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/gyno.2001.6334","article-title":"Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.","volume":"83","author":"Krivak","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R76-15-20210128","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/PAS.0b013e318161d1be","article-title":"Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.","volume":"32","author":"Soslow","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R77-15-20210128","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ygyno.2004.03.021","article-title":"Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.","volume":"93","author":"Amant","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R78-15-20210128","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/IGC.0b013e3181a84062","article-title":"Oral progesterone treatment in a young woman with mullerian adenosarcoma whose ovary was preserved: a case report.","volume":"20","author":"Lee","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"R79-15-20210128","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/gyno.2002.6585","article-title":"Use of medroxyprogesterone acetate in the treatment of Mullerian adenosarcoma: a case report.","volume":"85","author":"Hines","year":"2002","journal-title":"Gynecol Oncol"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCO.0b013e328363e0ef","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:39:24Z","timestamp":1621885164000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001622-201309000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0b013e328363e0ef","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}